Asset Management One
FOLD

Asset Management One’s Amicus Therapeutics FOLD Stock Holding History

Asset Management One’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-565,245
Closed -$4M – 1070
2016
Q3 		$4M Buy
565,245
+4,971
+0.9% +$33.6K 0.06% 381
2016
Q2 		$3.04M Sell
560,274
-28,847
-5% -$202K 0.05% 463
2016
Q1 		$4.71M Buy
589,121
+67,515
+13% +$478K 0.07% 332
2015
Q4 		$5.03M Buy
521,606
+140,311
+37% +$1.26M 0.08% 310
2015
Q3 		$4.94M Buy
381,295
+16,761
+5% +$263K 0.08% 326
2015
Q2 		$4.97M Buy
+364,534
New +$4.38M 0.07% 366

Other funds holding FOLD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Asset Management One's FOLD Position: Q4 2016 in Review

Asset Management One sold out of Amicus Therapeutics (FOLD) in Q4 2016, closing a stake of 565,245 shares — an estimated $4M sold.

Asset Management One first reported a position in FOLD in Q2 2015 and held it in 6 quarters. The position peaked at $5.03M in Q4 2015. 135 funds tracked by Wall St. Rank hold FOLD as of Q4 2016.

  • Asset Management One reported no remaining Amicus Therapeutics position as of Q4 2016 after selling out during the quarter.
  • Asset Management One sold 565,245 Amicus Therapeutics shares in Q4 2016, an estimated $4M.
  • Asset Management One first reported a position in Amicus Therapeutics in Q2 2015 and held it in 6 quarters.
  • Asset Management One's Amicus Therapeutics position peaked at $5.03M in Q4 2015.
  • 135 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q4 2016.

Based on Asset Management One's 13F filing for Q4 2016, filed 13 Feb 2017.